Roger Daltrey doesn't think so either.... and I agree. It's a lucrative business sadly...... we get the population hooked on the sugar diet and screw up the environment, then we create therapies to help people live with the results. Perhaps some researcher with a conscience will stumble upon the cure and then leak it out to an Elon Musk type who is more interested in helping humanity.
There's no single drug (including Vascepa) that's going to put cardiologists or pharma companies out of business.
A 25% RRR in CVD events is not going to wipe heart disease off the map like some sort of vaccine.
15M+ people in the U.S. have heart disease. If every single one of them took Vascepa, and you lower that to 12M, there's still plenty of disease to go around.
And since only a teeny fraction of those 15M+ are going to take Vascepa anyway, nobody is worried about Vascepa destroying CV practices.
Besides, people that take Vascepa STILL have heart disease, it's just being treated.
If anything, the industry would have been a lot more worried when statins went generic. Statins have a far greater impact on CVD than Vascepa ever will.